Big picture summary and What It Is

Armodafinil (often shortened to armod) is a prescription medication used to promote wakefulness. It contains the R-enantiomer of modafinil and belongs to the eugeroic class of drugs. It is intended to help manage excessive daytime sleepiness associated with defined sleep disorders and is not a replacement for getting adequate nightly sleep.

A photo snapshot reference facts:

• Active segment: armodafinil
• Primary aim: reduce excessive daytime sleepiness (EDS)
• Common tablet strengths available in the United States: for example 50 mg and 150 mg strengths are widely dispensed
• Related topics on this page: the study maps how interactions among individualss evolve over time. among drugs, an alternate possibility pharmacopoeia, forecasted prices, and statutory rules

When It Is Operational

Clinicians prescribe armodafinil to improve daytime alertness in adults with specific sleep conditions. Approved primary signs that indicate include:

• Narcolepsy as a medical condition with problematic daytime sleepiness
• Persistent sleepiness in people with obstructive sleep apnea (OSA) despite effective primary OSA treatment
• Shift work sleep disorder (SWD) to support alertness during scheduled work shifts

Some practitioners may use armodafinil off-label in situations such as treatment-resistant fatigue or selective attention problems. Such uses depend on clinician judgment and evidence. For legal and prescribing framework see Legal Recognition Status and Purchase Rules (US).

Recommendations for Dosing and Timing

Always follow the dosing protocol guidelines your prescriber provides. Typical adult dosing patterns commonly recommended are:

• For narcolepsy or OSA-related sleepiness: usually a single dose each morning; an initial commonly used amount is 150 mg once daily.
• For shift work sleep disorder: often taken approximately one hour before the start of the work shift; 150 mg is a frequent choice.

Some clinicians begin treatment at a lower dose (for example 50 mg) to evaluate tolerability. Because armodafinil can interfere with nighttime sleep, avoid taking it late in the day. It may be taken with or without food, but a large meal can slow the onset of effect.

See Handling a Skipped Dose for what to do if you forget a dose, and consult Communication and engagement and communication Between Drugs and Considerations when starting or stopping other medicines.

Safety Cautions and Advisories

In preparation before starting armodafinil, tell your prescriber about your full medical history. Special attention is needed in these circumstances:

• Operating machinery or driving: do not drive or operate heavy equipment until you know how this medication affects you; dizziness and visual problems have been reported.
• Mental health history: new or worsening mood changes, anxiety, agitation, or suicidal thinking require immediate reporting.
• Heart conditions: armodafinil can raise heart rate and blood pressure; people with cardiac disease or uncontrolled hypertension need evaluation and follow-up.
• Prenatal period and breastfeeding: discuss possible dangers and benefits ensure setup before use.
• Concurrent alcohol or other stimulants: combining substances may increase unfavorable effects; seek guidance from your clinician.
• Liver disease and advanced age: dose adjustments or extra tracking and monitoring of performance may be necessary in hepatic impairment and in older adults.

When this should not be used and Serious Alerts

• Known allergy or hypersensitivity to armodafinil, modafinil, or any ingredient in the product is a contraindication.
• Severe cardiac events or a history suggesting intolerance to stimulant-type medicines should be discussed with a prescriber before use.

Severe skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported with related drugs. If you develop a widespread rash, blistering, mouth sores, facial swelling, or unexplained fever, stop the medicine and seek immediate medical attention.

Possible Expected peripheral effects and risk signs

Usual adverse reactions reported by users include:

• Tension type pressure in my head
• Nausea or stomach distress
• Unsteadiness
• Trouble falling asleep or insomnia
• Nervousness, anxiety, or jitteriness

Seek urgent medical care if you experience chest pain, sudden very high blood pressure, severe mood disturbances, hallucinations, suicidal thoughts, or signs of a serious allergic reaction. For emergency contact information see An overdose case event Intervention Response and Emergency.

Drug Combinations and Exchanges and social the act of engaging in dialogues influence perceptions and decisions. and Considerations

Armodafinil affects liver enzymes and can alter levels of other medicines. Memorable tracking communication in actions helps measure engagement. include:

• Strong CYP3A4 inhibitors (for example ketoconazole, itraconazole) may increase armodafinil exposure.
• Armodafinil can induce CYP3A4 and reduce the effectiveness of some hormonal contraceptives containing ethinyl estradiol and norethindrone. Use a reliable nonhormonal backup method during treatment and for at least one month after stopping.
• Changes to CYP2C19 activity may raise concentrations of drugs such as diazepam, omeprazole, propranolol, and phenytoinpotencyly requiring dose adjustment or metric monitoring.
• Reported interplay between partiess between people can shape outcomes. include reduced cyclosporine exposure and implementable effects on warfarin and certain antiseizure medications; clinical constant monitoring is recommended.

Provide your clinician and pharmacist with a complete list of prescription medicines, over-the-counter products, and supplements before starting armodafinil. For dose specific guidance, consult the guidelines. Dosing Instructions and Timing.

What to Do After Forgetting a Dose

If you forget a scheduled dose, take the prescribed dose was missed as soon as you remember, unless the next dose is due soon. If it is late in the day, skip the prescribed dose was missed to avoid insomnia. Do not take two doses in one go to compensate for a prescribed dose was missed.

Recheck the prior material Safe Dosing Guidance and Timing for typical dosing schedule patterns and timing considerations.

Overdose risk Care and Response and Emergency

Overdose episode symptoms may include marked agitation, restlessness, confusion, hallucinations, tremor, rapid heartbeat, nausea, and diarrhea. If you believe an take an overdose has occurred, call 911 or contact the US Poison Control Center at 1-800-222-1222 immediately.

Warehousing and Handling Recommendations

• Store at normal room temperature, approximately 20 to 25 C (68 to 77 F).
• Keep the tablets dry and out of direct sunlight.
• Store medications in a secure place out of reach of children and pets, preferably in a child-resistant container.

Feasible contingency options and Brief Comparison

If armodafinil is unsuitable or not tolerated, there are several a second possibility pharmacopoeia and approaches. Brief contrasts follow:

• Modafinil (racemic mixture): used for the same main telltale signs as armodafinil. Clinical effect is similar for many patients; some notice small differences in onset or duration. Both are Schedule IV in the US.
• Solriamfetol (Sunosi): a norepinephrine and dopamine reuptake inhibitor approved for EDS in OSA and narcolepsy. It can raise blood pressure and heart rate and is a controlled drug.
• Pitolisant (Wakix): works via histamine H3 receptor antagonism/inverse agonism and is approved for narcolepsy. It is not a controlled substance in the US and may help some patients with cataplexy.
• CNS stimulants (for example methylphenidate, amphetamine salts): sometimes used when other options fail but carry higher abuse potential and are Schedule II substances with stricter prescribing rules.
• Nonpharmacologic strategies: optimizing CPAP for OSA, structured nap schedules, light therapy, and strong sleep hygiene practices are important complementary measures.

Choice depends on clinical appropriateness, side effect profiles, insurance coverage, and out-of-pocket cost. See Estimate Prices (USD) for rough cost assessment.

Estimate Prices (USD)

Retail prices in the United States vary widely depending on pharmacy, dose, brand versus generic, and any coupons or assistance. The figures below are approximate and intended for general comparison only.

• Generic armodafinil (typical 50 mg or 150 mg tablets): discounted prices often range from about $0.80 to $3.00 per tablet; a 30-tablet supply without discounts may be roughly $150 to $350.
• Brand armodafinil (for example Nuvigil): retail per-tablet prices commonly fall in the $10 to $20 range; a month of therapy without savings can approach $600 to $900.
• Generic modafinil: coupon or discount prices often about $1 to $4 per tablet; historical brand prices were substantially higher.
• Solriamfetol (Sunosi): typical retail cost for a 30-day supply often ranges from $700 to $900.
• Pitolisant (Wakix): list prices can be several thousand dollars per month, though manufacturer assistance programs may reduce patient cost.
• Generic stimulant medications: wide pricing overview range; some generics may cost from about $10 to $60 per month depending on formulation and dose.

To get current local pricing approach check nearby pharmacies, online prices compared side by side tools, your insurer's pharmacy benefits, and manufacturer savings programs. Coupons, discount cards, and certain pharmacies can substantially lower out-of-pocket costs for eligible patients.

Legal Status Panorama of the tip topic and Purchase Rules in the United States

Important legal points to bear in mind:

• Controlled substance classification: armodafinil is a Schedule IV controlled substance under US federal law.
• Prescription requirement: a valid prescription from a licensed prescriber is required to obtain armodafinil. Schedule IV medications generally may allow up to five refills within six months under federal rules unless state law specifies otherwise.
• Electronic prescribing and telemedicine: electronic prescriptions are commonly used. Telemedicine rules and DEA guidance can change; confirm current federal and state requirements before relying on remote prescribing.
• Importation: bringing controlled substances into the United States without appropriate authorization is typically prohibited. When ordering online, use licensed US pharmacies and test the system credentials such as NABP accreditation.
• Workplace and safety-sensitive roles: employers may have policies about the use of controlled stimulants in safety-sensitive positions; occupational health or employer policies may require disclosure in certain situations.
• Off-label prescribing: clinicians may prescribe off-label when medically appropriate, but manufacturers cannot market drugs for unapproved symptoms.
• Athletes and sport regulations: stimulants including modafinil and related drugs are often prohibited by sporting authorities; athletes should consult relevant bodies about Therapeutic Use Exemptions.

State laws, insurer policies, and pharmacy practices vary. Confirm up-to-date legislation and regulatory oversight details with your prescriber, pharmacist, or legal advisor before obtaining or using armodafinil.